What’s Slowing Your Clinical Trial? Probably Everything that Can Be Outsourced
Why are patients still driving hours to participate in clinical trials? With EVERSANA, they don’t have to. Our Direct-to-Participant model delivers therapies directly to them; no site bottlenecks, no paperwork nightmares, no unnecessary friction. There’s also a key benefit to the trial site: no inventory management.
We simplify everything—from first dose to final data point—by combining medication delivery, digital engagement and personalized support.
- Convenient Dispensing – Ship therapies straight to participants, eliminating unnecessary site visits and making clinical trials more accessible.
- Higher Retention and Engagement – Keep participants on therapy with personalized support, digital tools and seamless delivery.
- Lighter Site Load – Free up trial sites from administrative work, product storage and medication handling, freeing up staff to focus on the science.
- Faster Data Collection & Trial Results – With fewer delays and better data flow, you get trial results sooner and bring a new therapy to market faster.
Proven Success in the Field
A top pharma brand partnered with EVERSANA to modernize their clinical trial approach. By implementing our Direct-to-Participant dispensing model, they achieved:
- Over 60% reduction in site visits, accelerating participant recruitment and improving retention.
- Expanded trial accessibility, allowing participants to receive therapies at home, work and local retail pharmacies.
- Optimized site and sponsor resources, minimizing administrative burdens and enabling staff to focus on core clinical activities.